FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064873017> ?p ?o ?g. }

• W2064873017 endingPage "536" @default.
• W2064873017 startingPage "526" @default.
• W2064873017 abstract "We investigated the use of mice transgenic for human leucocyte antigen (HLA) A*0201 antigen-binding domains to test vaccines composed of defined HLA A*0201-restricted cytotoxic T-lymphocyte (CTL) epitopes of human papillomavirus (HPV) type 16 E7 oncoprotein. HPV is detected in >90% of cervical carcinomas. HPV16 E7 oncoprotein transforms cells of the uterine cervix and functions as a tumour-associated antigen to which immunotherapeutic strategies may be directed. We report that although the HLA A*0201 E7 epitope peptides function both to prime for E7 CTL responses, and to sensitize target cells for E7-directed CTL killing in situations where antigen processing is not required, the epitopes are not processed out of either endogenously expressed or immunization-introduced E7, by the mouse antigen-processing and presentation machinery. Thus (1) CTL induced by HLA A*0201 peptide immunization killed E7 peptide-pulsed target cells, but did not kill target cells expressing whole E7; (2) immunization with whole E7 protein did not elicit CTL directed to HLA A*0201-restricted E7 CTL epitopes; (3) HLA A*0201-restricted CTL epitopes expressed in the context of a DNA polytope vaccine did not activate E7-specific T cells either in 'conventional' HLA A*0201 transgenic (A2.1Kb) mice, or in HHD transgenic mice in which expression of endogenous H-2 class 1 is precluded; and (4) HLA A*0201 E7 peptide epitope immunization was incapable of preventing the growth of an HLA A*0201- and E7-expressing tumour. There are generic implications for the universal applicability of HLA-class 1 transgenic mice for studies of human CTL epitope presentation in murine models of human infectious disease where recognition of endogenously processed antigen is necessary. There are also specific implications for the use of HLA A2 transgenic mice for the development of E7-based therapeutic vaccines for cervical cancer." @default.
• W2064873017 created "2016-06-24" @default.
• W2064873017 creator A5051306835 @default.
• W2064873017 creator A5081494788 @default.
• W2064873017 creator A5085045628 @default.
• W2064873017 creator A5087650544 @default.
• W2064873017 date "2002-08-01" @default.
• W2064873017 modified "2023-10-06" @default.
• W2064873017 title "Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein" @default.
• W2064873017 cites W1509190187 @default.
• W2064873017 cites W1522473566 @default.
• W2064873017 cites W1537609529 @default.
• W2064873017 cites W1578943666 @default.
• W2064873017 cites W1607047960 @default.
• W2064873017 cites W1850519654 @default.
• W2064873017 cites W1946675397 @default.
• W2064873017 cites W1949342640 @default.
• W2064873017 cites W1964435516 @default.
• W2064873017 cites W1966505472 @default.
• W2064873017 cites W1967257604 @default.
• W2064873017 cites W1977235120 @default.
• W2064873017 cites W1978146796 @default.
• W2064873017 cites W1980992414 @default.
• W2064873017 cites W1981383297 @default.
• W2064873017 cites W1988832652 @default.
• W2064873017 cites W2011457215 @default.
• W2064873017 cites W2020934211 @default.
• W2064873017 cites W2022274936 @default.
• W2064873017 cites W2026470830 @default.
• W2064873017 cites W2042955728 @default.
• W2064873017 cites W2047138171 @default.
• W2064873017 cites W2050784170 @default.
• W2064873017 cites W2063929734 @default.
• W2064873017 cites W2072461945 @default.
• W2064873017 cites W2078397942 @default.
• W2064873017 cites W2078760290 @default.
• W2064873017 cites W2084416493 @default.
• W2064873017 cites W2084747305 @default.
• W2064873017 cites W2092974310 @default.
• W2064873017 cites W2093844128 @default.
• W2064873017 cites W2100069498 @default.
• W2064873017 cites W2112184010 @default.
• W2064873017 cites W2119347540 @default.
• W2064873017 cites W2120403825 @default.
• W2064873017 cites W2124446900 @default.
• W2064873017 cites W2132198322 @default.
• W2064873017 cites W2138205821 @default.
• W2064873017 cites W2156230656 @default.
• W2064873017 cites W2159663324 @default.
• W2064873017 cites W2164339006 @default.
• W2064873017 cites W2169044551 @default.
• W2064873017 cites W2312653119 @default.
• W2064873017 cites W2312909977 @default.
• W2064873017 cites W4242393027 @default.
• W2064873017 doi "https://doi.org/10.1046/j.1365-2567.2002.01442.x" @default.
• W2064873017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1782761" @default.
• W2064873017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12153516" @default.
• W2064873017 hasPublicationYear "2002" @default.
• W2064873017 type Work @default.
• W2064873017 sameAs 2064873017 @default.
• W2064873017 citedByCount "28" @default.
• W2064873017 countsByYear W20648730172013 @default.
• W2064873017 countsByYear W20648730172014 @default.
• W2064873017 countsByYear W20648730172017 @default.
• W2064873017 countsByYear W20648730172018 @default.
• W2064873017 countsByYear W20648730172021 @default.
• W2064873017 crossrefType "journal-article" @default.
• W2064873017 hasAuthorship W2064873017A5051306835 @default.
• W2064873017 hasAuthorship W2064873017A5081494788 @default.
• W2064873017 hasAuthorship W2064873017A5085045628 @default.
• W2064873017 hasAuthorship W2064873017A5087650544 @default.
• W2064873017 hasBestOaLocation W20648730172 @default.
• W2064873017 hasConcept C108249834 @default.
• W2064873017 hasConcept C147483822 @default.
• W2064873017 hasConcept C147969180 @default.
• W2064873017 hasConcept C153911025 @default.
• W2064873017 hasConcept C154317977 @default.
• W2064873017 hasConcept C159047783 @default.
• W2064873017 hasConcept C167672396 @default.
• W2064873017 hasConcept C170627219 @default.
• W2064873017 hasConcept C188280979 @default.
• W2064873017 hasConcept C195616568 @default.
• W2064873017 hasConcept C202751555 @default.
• W2064873017 hasConcept C203014093 @default.
• W2064873017 hasConcept C207936829 @default.
• W2064873017 hasConcept C2776090121 @default.
• W2064873017 hasConcept C54355233 @default.
• W2064873017 hasConcept C83464605 @default.
• W2064873017 hasConcept C86803240 @default.
• W2064873017 hasConcept C8891405 @default.
• W2064873017 hasConceptScore W2064873017C108249834 @default.
• W2064873017 hasConceptScore W2064873017C147483822 @default.
• W2064873017 hasConceptScore W2064873017C147969180 @default.
• W2064873017 hasConceptScore W2064873017C153911025 @default.
• W2064873017 hasConceptScore W2064873017C154317977 @default.
• W2064873017 hasConceptScore W2064873017C159047783 @default.
• W2064873017 hasConceptScore W2064873017C167672396 @default.
• W2064873017 hasConceptScore W2064873017C170627219 @default.

• next